glp-1 dementia study Could diabetes and weight loss drugs treat Alzheimer's disease? GLP-1 Genetics: How Genes Affect

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly prescribed for weight management in adults with obesity or overweight with related health conditions

( 10.1111/j.1464-5491.2012.03745.x) [DOI] [PubMed] [Google Scholar] Habegger KM Heppner KM Geary N Bartness TJ DiMarchi R & Tschop MH

Response can depend on dose, adherence, dietary choices, activity level, medications, and medical history

Some patients respond better to one GLP-1 drug than another due to genetic variation in GLP1R gene expression or differences in how their bodies metabolize each compound

GLP-1 receptor agonists are medications that mimic a natural hormone in the body (glucagon-like peptide-1) to help regulate blood sugar and control appetite